Reference
NICE. NICE draft guidance recommends new treatment option for people with early breast cancer. Internet Document : 7 May 2020. Available from: URL: https://www.nice.org.uk/news/article/nice-draft-guidance-recommends-new-treatment-option-for-people-with-early-breast-cancer
Rights and permissions
About this article
Cite this article
UK NICE recommends trastuzumab emtansine for HER2-positive breast cancer. PharmacoEcon Outcomes News 853, 35 (2020). https://doi.org/10.1007/s40274-020-6830-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6830-5